← All allergens

Cashew allergy

Cashew allergy is an IgE-mediated immune reaction to the seed-storage proteins in Anacardium occidentale, the cashew tree, and it is among the most common and most severe tree-nut allergies in children. In plain terms: your child’s immune system reads certain cashew proteins as a threat, and a reaction can run from hives to a whole-body allergic reaction that affects breathing and blood pressure, called anaphylaxis. It is a true allergy, not a sensitivity or an intolerance. Tree-nut allergy affects roughly 1.2 percent of US children (Gupta 2018), and cashew is one of the tree nuts most often involved in serious childhood reactions. Unlike milk or egg, cashew is infrequently outgrown, and it often shows up at a child’s first known taste.

If your child was just diagnosed, read this first.

This page is long on purpose. It is also the page you will come back to for years. You do not need all of it today. This week, this is what matters:

  • Carry two epinephrine auto-injectors everywhere your child goes, and learn the few signs that mean use one now. That is the section to read tonight (Emergency preparedness, below). If you do not have the prescription yet, that is the first call to your allergist or pediatrician.
  • Read every label, every time. The words to catch are cashew, anacardium, kaju, and caju (Reading labels, below).
  • Cashew and pistachio usually travel together. They are close botanical cousins and most allergists manage them as a pair, so treat pistachio as off the list too until an allergist tells you otherwise (Cross-reactivity, below).
  • Most other tree nuts are a separate question, not an automatic yes and not an automatic no. They are tested, not assumed (Cross-reactivity, below).
  • You do not have to understand the protein science to keep your child safe. The components and the test numbers are for unhurried conversations with your allergist.
  • Ask your allergist about the one high-value test by name: Ana o 3 (Components, below).

Everything else here is waiting for you, in roughly the order the questions tend to come up. Read it when you want it.

Where a fact below is clinical, it carries its source. None of it is a substitute for your allergist.

What cashew allergy is, and who has it

Cashew allergy is an IgE-mediated immediate-type food allergy, and cashew is among the tree nuts most often linked to severe, whole-body reactions in children. That is the reason for everything practical on this page: the auto-injectors, the label habit, the written plan. When your child eats cashew, IgE antibodies on their immune cells latch onto the cashew proteins and trigger a release of histamine and other chemicals within minutes. That release is the reaction.

Cashew is a true tree nut, in the plant family Anacardiaceae. That family matters more than it does for most allergens, because it is also home to pistachio, pink peppercorn, mango, and sumac, and cashew genuinely cross-reacts with some of them (Cross-reactivity, below). This is different from peanut, where the family overlap is mostly reassuring. For cashew, the family is part of the caution.

Tree-nut allergy runs about 1.2 percent in US children (Gupta 2018, a nationally representative parent-report survey), and cashew is one of the tree nuts most commonly involved within that group. A clean standalone cashew prevalence is not isolated in the national survey, so this page does not attach a single percentage to cashew specifically. Onset is usually early, often before age two, and frequently at a first known exposure, so the absence of a previous reaction does not mean a child is in the clear (Röntynen 2025).

Diagnosis combines your child’s history with testing, and for cashew the testing has one high-value move worth knowing about. The next section is what it is.

The components that drive severity

Cashew is not one thing to the immune system. It is a handful of proteins, and which one your child reacts to changes how serious the allergy tends to be. For cashew there is one marker that carries most of the weight, and asking for it by name is the highest-value thing you can do.

A standard cashew test (the skin prick, or the basic blood test) only tells you the immune system has noticed cashew at all. A more detailed test, component testing, breaks that down protein by protein. For cashew the protein that matters most is the one your allergist calls Ana o 3. It is the strongest signal for the serious, whole-body kind of cashew allergy, and it is a far better discriminator than the standard whole-cashew test. Unlike peanut, cashew does not have a well-established “usually mild” component to reassure you with; the cashew picture is mostly about how strong the Ana o 3 signal is.

So the high-value move is simple: ask your allergist to measure Ana o 3-specific IgE, not just whole-cashew IgE, and ask what the result means for severity and for the chance of outgrowing it. You do not need to learn the protein names or the lab numbers yourself. They are below, written so the words on your child’s lab report mean something when you want them to.

The deeper version: the cashew proteins and the test numbers (for your allergist conversation)

Component-resolved testing is run by ImmunoCAP (singleplex for Ana o 3) or by a multiplex panel (ISAC or ALEX2, the latter with a CCD inhibitor that cuts carbohydrate-driven false positives). The cashew components:

Ana o 3 is the 2S albumin and the protein that matters most. It is heat-stable and digestion-stable, which is why roasting does not defuse cashew and why a reaction can be whole-body. Ana o 3-specific IgE discriminates allergic from tolerant children far better than whole-cashew IgE (ROC area under the curve about 0.94 versus 0.78). A two-step approach (whole-cashew IgE first, then Ana o 3) using an Ana o 3 cutoff above 0.32 kUA/L reached about 95 percent specificity and 90 percent sensitivity and cut the share of children needing an oral food challenge from about two-thirds to about one in eight (Dang 2022). A roughly 95 percent probability of clinical allergy is estimable near 2.0 kU/L of Ana o 3 in a pediatric cohort (Lange 2017). These are pediatric, assay-dependent decision points your allergist reads against your child’s history, not universal cutoffs to decode on your own.

Ana o 1 (a 7S vicilin) and Ana o 2 (an 11S legumin) are the other storage proteins. A positive test to these is not reassuring: for cashew, pistachio, walnut, and pecan, the storage proteins are a red flag for whole-body reactivity, not a minor finding.

One note for later: these figures describe a child who is not in active immunotherapy. Cashew OIT, where it is offered, changes the picture, and that is in Treatment options.

Cross-reactivity, real and cautionary

This is the section where cashew differs most from peanut, and the honest version leads with the caution, not a reassurance. Cashew’s cross-reactions are realer than most. The good news that does exist is narrow and specific, and it comes after the part that actually changes what is on your child’s plate.

Pistachio travels with cashew. Cashew and pistachio are close cousins in the Anacardiaceae family and they cross-react strongly through their storage proteins (cashew Ana o 1, pistachio Pis v 3); a child allergic to one is very often allergic to the other. Most allergists manage the two as a pair. Treat pistachio as off the list unless a supervised challenge with your allergist says otherwise.

Pink peppercorn is a real, hidden cross-reactant. Pink peppercorn comes from a Schinus plant in the same Anacardiaceae family, and it is cross-reactive in cashew-allergic and pistachio-allergic children, with documented co-sensitization and at least one reported anaphylaxis. It hides unlabeled in rainbow and five-pepper peppermill blends, charcuterie seasoning, and gin botanicals.

Sumac is a caution, not a cleared food. Cashew and sumac are both Anacardiaceae, and lab testing shows IgE cross-reactivity. There are no formal food-challenge studies, and a published case describes a cashew-allergic teenager reacting to sumac, so a positive sumac test is not something we can call safe; precautionary avoidance is the conservative default.

What the science does NOT yet let us reassure you about. Whether most cashew-allergic children can safely eat the unrelated tree nuts (almond, hazelnut, walnut, pecan, macadamia) is a real and common question, and the honest answer right now is that it is tested, not assumed. Walnut and the other storage-protein nuts are co-occurrence questions handled by your allergist, and a blanket “you can eat the rest” is not something this page will tell you, because the evidence for cashew does not support it. Your allergist tests and decides, nut by nut.

The one clear reassurance: coconut. Coconut, despite the name and the FDA’s labeling rule, is botanically a fruit (a drupe), not a tree nut, and most tree-nut-allergic people tolerate it. Coconut is usually a yes, confirmed with your allergist.

Hidden sources

Cashew is one of the most consequential hidden-source tree nuts, because of the rise of plant-based dairy. These are worth a one-time read now; after that you will spot them on your own.

Vegan dairy substitutes. Cashew paste is the most common base for vegan cream cheese, mozzarella, ricotta, queso, sour cream, yoghurt, and many non-dairy ice creams. Treat any vegan dairy substitute as a likely cashew source until the label confirms otherwise.

Indian, Thai, and pesto cooking. Cashew paste is a standard, often-undeclared creamy thickener in Indian sauces like korma, shahi paneer, and butter chicken, and kaju katli is solid cashew. Most commercial and restaurant pestos substitute cashew or walnut for pine nuts without saying so.

Snack bars and confectionery. Cashew shows up as cashew butter or cashew flour in energy and protein bars and in confectionery, often without prominence beyond the ingredient line.

Pink peppercorn blends. Rainbow and five-pepper peppermill blends carry pink peppercorn, the cross-reactive Anacardiaceae spice from Cross-reactivity, usually unlabeled as an allergen.

A confusion worth clearing. A rash from handling raw cashew shells or cashew nut shell liquid is a different thing from the food allergy. It is a delayed, poison-ivy-type contact reaction (a Type IV reaction to urushiol-class compounds in the shell), not the IgE food allergy, and it does not mean the food allergy is more severe or change the avoidance plan (Cosmoderma 2022).

How exposure actually happens

The routes parents fear most are usually not the ones that cause serious reactions. Eating cashew is. The rest are lower-risk than they feel, with a couple of specific exceptions.

Eating it (high). Swallowing cashew protein is the route that causes whole-body reactions. Everything else is far behind it. Cooking does not help: cashew’s storage proteins are heat-stable, so roasted or cooked cashew stays allergenic.

Skin contact (moderate, higher with eczema). Cashew on intact skin usually causes at most a local reaction. The real exception is broken or eczematous skin, where the risk is meaningfully higher, the same dual-allergen-exposure logic that operates for other potent food allergens.

Breathing it in (low, with one exception). Cashew is not volatile the way shellfish cooking aerosols are, so ambient smell is low-risk. The exception is aerosolized cashew dust in bulk-processing or occupational settings.

Kissing and saliva (documented, less quantified than peanut). Cashew protein in saliva after eating is plausible and worth the same quick hand-and-mouth wash habit, though it is less precisely studied for cashew than for peanut.

If your child is in cashew immunotherapy, one note: the risk levels above describe ordinary life outside active treatment. During active OIT build-up, the risk from an incidental exposure is modulated, and Treatment options is where that is explained.

Reading labels

This is the habit that does the most day-to-day work, and it gets fast. The words to scan for are cashew, anacardium occidentale, and the imported-product terms kaju and caju (common on South Asian and Brazilian products). In the US, tree nuts including cashew must be named specifically under FALCPA, and the EU requires nut declaration under Regulation 1169/2011 (FALCPA; EU 1169).

A few terms are signals to slow down: pesto (frequent undisclosed cashew or walnut for pine nuts), any vegan cheese, vegan cream, or plant-based dairy (cashew is the default base), and rainbow or five-pepper peppercorn blends (pink peppercorn). When a term is unclear and the manufacturer will not say, treat it as a reason to call the company, not a reason to assume it is safe.

Then there are the precautionary labels: “may contain tree nuts,” “made in a facility that processes tree nuts.” These are voluntary and unregulated in both the US and the EU, so they are not a reliable measure of how much risk is actually present. How strictly you treat them is a personal call along a spectrum, weighing a real but variable cross-contact risk against ruling out a large share of the grocery store. This page will not pick that threshold for you.

Severity, and what predicts a bad reaction

The strongest population-level predictor of a severe cashew reaction is sensitization to Ana o 3, the protein from the components section, and its magnitude (Lange 2017, Dang 2022). A history of a previous severe reaction is the next strongest input. Cashew has no well-established cofactor syndrome of the kind LTP foods have, so the picture is mostly about the Ana o 3 signal and the history.

Here is the part that justifies always carrying epinephrine. The size of the last reaction does not reliably predict the next one, and cashew reactions can be severe at a first known exposure. A child whose only reaction so far was mild can still have anaphylaxis next time. That is not a reason to live in fear; it is the single reason the auto-injector travels everywhere.

These thresholds are for the unmodified case. The figures above describe a cashew-allergic child who is not in active oral immunotherapy. During active cashew OIT build-up, the dose that can set off an incidental reaction is modulated, often downward, so the numbers here are the baseline and active treatment shifts them. Treatment options is the home for that.

Emergency preparedness

Cashew anaphylaxis is treated epinephrine-first. Epinephrine is the first-line treatment for a severe reaction, not an antihistamine and not a wait-and-see. If you see anaphylaxis, you give epinephrine and then you call emergency services.

The signs that mean epinephrine now include any two body systems reacting at once (for example hives plus vomiting), or any single severe sign on its own: trouble breathing, throat tightness, a hoarse or weak cry, repetitive coughing, pale or floppy appearance, or a sense of impending doom in a child old enough to say so. When you are unsure, the guidance is to give epinephrine, because the danger of withholding it in a true reaction is far greater than the danger of giving it when it turns out you did not need to.

After giving epinephrine, call emergency services and lay the child down with legs raised, unless breathing is the main problem, in which case let them sit up. A second dose may be needed if there is no improvement in about five minutes. Every cashew-allergic child should have a written anaphylaxis action plan and two epinephrine auto-injectors that go everywhere the child goes.

This section is general. Your child’s own plan is the specific one, and it is the one to follow.

When you can’t tell what’s happening

The hardest moments are usually not the clear reactions. They are the ambiguous ones. A flushed cheek after a new food. A single cough. A child who says their tummy hurts an hour after a snack you did not pack. Telling the start of a reaction apart from an ordinary toddler complaint is genuinely hard, and it does not resolve cleanly from across the room.

The posture that works is to treat the spectrum, not to diagnose it in the moment. Know your action plan’s override signs cold, watch whether more than one body system is involved rather than fixating on a single symptom, and accept that you will sometimes give epinephrine or call the allergist for something that turns out to be nothing. That is the system working the way it is supposed to.

The competence here builds slowly, over many ambiguous afternoons. It shows up as a shorter pause before you act.

Treatment options

Strict avoidance is the floor, and everything else is decided on top of it. Avoidance plus a written action plan plus epinephrine within reach is the standing setup for cashew-allergic children. Because pistachio travels with cashew (see Cross-reactivity), avoidance practically extends to pistachio unless a supervised challenge says otherwise.

Cashew is different from peanut in one important way: there is no FDA-approved cashew treatment. There is no cashew version of Palforzia. What exists is emerging.

Cashew oral immunotherapy (emerging, not approved). Cashew OIT feeds measured, slowly increasing doses of cashew protein under medical supervision to train the body toward tolerance. It is offered in specialist and research settings, not as an approved product. In the NUT CRACKER cohort (50 cashew-allergic patients aged 4 and up, target maintenance 4000 mg cashew protein), 44 of 50 (88 percent) were desensitized to 4000 mg versus none of the untreated controls, and notably it cross-desensitized all 35 pistachio-co-allergic patients and about half of the walnut-co-allergic ones (Elizur 2022, the NUT CRACKER study). Enrollment thresholds, maintenance doses, and eligibility vary by center, and because cashew OIT is not a regulator-approved product, this page does not name a starting dose. That is your allergist’s call, with you.

During active cashew OIT, the threshold for an incidental exposure is modulated. This matters only if your child is in or starting OIT. If you are not there yet, you can skip it for now.

If your child is in or starting cashew OIT: how active treatment changes incidental-exposure risk

Once a child is in active build-up dosing, the dose of incidental cashew that can trigger a reaction shifts, and the literature documents the direction as downward during build-up (Elizur 2022). Augmentation factors (exercise, intercurrent illness, missed doses, fasting) can lower it further on a given day. The unmodified Ana o 3 thresholds in the components and severity sections do not describe the active-treatment state. Two things follow. First, vigilance against incidental exposure during build-up is not optional, and the home or school setting may need temporary adjustment that would not be needed before OIT or after maintenance is stable; the specific adjustments are your allergist and the protocol’s written guidance, not this page. Second, the modulation is not permanent; once a child reaches stable maintenance, the threshold typically returns toward, though not necessarily to, the unmodified state. The per-child magnitude is not established, only the direction.

SLIT and EPIT (investigational). Sublingual and epicutaneous immunotherapy for cashew are investigational, with sparse pediatric data. They are named here as a pipeline direction, not a recommended option.

Not medical advice. Whether to treat at all, and how, is a conversation with your allergist.

Day-to-day living

School and day care. A cashew-allergic child needs a written plan on file, epinephrine truly accessible, trained staff, and a clear routine for snacks, classroom parties, and substitute teachers. In US public schools, a 504 plan is the usual way to put that in writing. Flag pistachio alongside cashew.

Restaurants. The risk is cross-contact and hidden cashew more than the obvious menu item. Indian, Thai, vegan, and bakery spots carry higher cashew risk (sauces, vegan dairy, pesto, desserts). A chef card that names cashew and pistachio plainly does more than a verbal order across a loud kitchen.

Travel. Bring more epinephrine than you think you need, carry food you trust, and look up pharmacies and emergency numbers before you land. Cashew is common in South and Southeast Asian cuisines, so confirm local dishes carefully.

Holidays and gatherings. Mixed-nut bowls, baklava and pistachio desserts, charcuterie boards with pink-peppercorn seasoning, and vegan dishes are the cashew-dense settings. Bringing your child’s own food and being plain with hosts beats hoping a buffet is safe.

Prognosis and outgrowing

Cashew is among the more persistent food allergies, infrequently outgrown, and it sits at the persistent end of the tree nuts (Röntynen 2025). The most informative early sign of outgrowing is a falling Ana o 3-specific IgE over serial testing; in one cohort a roughly 50 percent or greater fall in Ana o 3 predicted a negative rechallenge with high specificity, while a shrinking skin-prick test did not discriminate (Röntynen 2025).

Reassessment cadence is individualized, commonly every one to three years depending on history, more often for a younger child with a milder history and less aggressively after a severe reaction. The one definitive test of outgrowing it is a supervised oral food challenge; falling numbers are encouraging but supportive, not proof.

Questions for your allergist

You do not have to walk in knowing the science. You have to walk in with the right questions, and these are them.

  1. What is my child’s Ana o 3-specific IgE value, not just whole-cashew IgE, and what does its level and its trend mean for severity and for outgrowing?
  2. Should we treat pistachio as off-limits too, and is a supervised challenge ever worth considering for it or for the other tree nuts?
  3. Which hidden cashew sources (vegan dairy, Indian and Thai sauces, pesto, pink peppercorn) matter most for how we actually eat?
  4. Is my child a candidate for cashew OIT given that it is emerging and not FDA-approved, and what are the trade-offs for us specifically?
  5. If my child is in or considering cashew OIT, how does active treatment change the day-to-day vigilance around incidental exposure, and how do exercise, illness, or missed doses change it?
  6. When and how should we reassess to see if the allergy is resolving?
  7. What will epinephrine, and any treatment we are considering, actually cost us, and what does our insurance cover?

The frame: how to hold this

There are two worlds, and a severe food allergy moves a family from one into the other. In the recoverable world, a mistake is a lesson. A forgotten jacket is a cold afternoon. In the irrecoverable world, one wrong protein is not a lesson, because the cost of the error can be the child. When someone tells an allergy parent to relax, they are speaking from the first world to someone who has had to move to the second. They think the parent is anxious. The parent is not anxious. The parent is calibrated.

The work, then, is to sort what is on your side of the line from what is not. On your side: the labels you read, the Ana o 3 test you ask for, the epinephrine that travels with the child, the chef card that names cashew and pistachio, the plan on file at school. Not on your side: the kitchen that purees cashew into a sauce and does not say so, the relative who thinks one bite is kindness, the manufacturer whose precautionary label is voluntary. You do the things on your side fully, and you stop apologizing for them. And you hold, without pretending otherwise, that the other side is real and partly random, and that a stacked defense reduces the risk without ever closing the gap to zero.

This page does not promise safety. It lays out the layers and names the gap, and it leaves the calibration to you and your allergist, who actually know your child.

  • Cashew and pistachio cross-reactivity, the deep version
  • The Anacardiaceae family: cashew, pistachio, pink peppercorn, mango, sumac
  • Where cashew hides: the deep label-reading guide
  • Cashew OIT, what “emerging” means
  • Building a cashew and pistachio 504 plan
  • Restaurants with a cashew-allergic child

These companion pages are being written and will be linked here as each one goes live.

Frequently asked questions

Is cashew a tree nut?

Yes. Cashew is a true tree nut in the Anacardiaceae family, which also includes pistachio, mango, pink peppercorn, and sumac. That family connection is why cashew and pistachio so often go together (see Cross-reactivity).

Can my cashew-allergic child eat pistachio?

Usually not without an allergist’s say-so. Cashew and pistachio are close cousins and cross-react strongly, so most allergists manage them as a pair and treat pistachio as off the list unless a supervised challenge clears it (see Cross-reactivity).

Does cooking or roasting make cashew safe?

No. Cashew’s storage proteins are heat-stable and digestion-stable, so roasting and cooking do not make cashew safe for a cashew-allergic child (Lange 2017).

Is coconut a problem for a cashew allergy?

Usually not. Coconut is botanically a fruit, not a tree nut, and most tree-nut-allergic people tolerate it, though confirm with your allergist.

Is there a treatment for cashew allergy?

There is no FDA-approved cashew treatment yet. Cashew oral immunotherapy is emerging and offered in specialist settings, and in one study it desensitized most treated children and cross-protected against pistachio (Elizur 2022). It is a conversation with your allergist, not a self-directed step (see Treatment options).

References and medical review

This page is pending independent medical review; the note at the top of the page applies until a reviewer is assigned. The references below resolve every in-body citation. The cross-reactivity, hidden-source, and reassurance claims (pistachio, pink peppercorn, sumac, the storage-protein caution, the vegan-dairy and Indian-cuisine hidden sources, and the coconut reassurance) are drawn from the project’s verified cross-reactivity floor, each carrying its own source there.

  1. Gupta RS, Warren CM, Smith BM, et al. The Public Health Impact of Parent-Reported Childhood Food Allergies in the United States. Pediatrics. 2018;142(6):e20181235. https://doi.org/10.1542/peds.2018-1235
  2. Lange L, Lasota L, Finger A, et al. Ana o 3-specific IgE is a good predictor for clinically relevant cashew allergy in children. Allergy. 2017;72(4):598-603. https://doi.org/10.1111/all.13050
  3. Dang TD, Peters RL, Koplin JJ, et al. Ana o 3 sIgE testing increases the accuracy of cashew allergy diagnosis using a two-step model. Pediatr Allergy Immunol. 2022;33(1):e13705. https://doi.org/10.1111/pai.13705
  4. Elizur A, Appel MY, Nachshon L, et al. Cashew oral immunotherapy for desensitizing cashew-pistachio allergy (NUT CRACKER study). Allergy. 2022;77(6):1863-1872. https://doi.org/10.1111/all.15212
  5. Röntynen P, et al. Natural Course and Predictors of Clinical Resolution in Pediatric Cashew Nut Allergy. Allergy. 2025. https://doi.org/10.1111/all.16664
  6. Occupational dermatitis to cashew nut (cashew nut shell liquid, a urushiol-class contact reaction distinct from the food allergy). Cosmoderma. 2022. https://cosmoderma.org/occupational-dermatitis-to-cashew-nut/
  7. IgE Cross-Reactivity of Cashew Nut Allergens (Anacardiaceae cross-reactivity, including pink peppercorn). Int Arch Allergy Immunol. 2019;178(1):19. https://karger.com/iaa/article/178/1/19/168275/IgE-Cross-Reactivity-of-Cashew-Nut-Allergens
  8. Food Allergen Labeling and Consumer Protection Act of 2004 (FALCPA); tree nuts named specifically. https://www.fda.gov/food/nutrition-food-labeling-and-critical-foods/food-allergies
  9. Regulation (EU) No 1169/2011 (Annex II allergens, nuts). https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32011R1169

← All allergens